Selen Hürmüzlü Közler

Dr. Selen Hürmüzlü Közler

Kocaeli University
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2021 in Current Medical Research and Opinion
Verified
Journal Article
Closed access
SKSelen Hürmüzlü Közler
Selen Hürmüzlü Közler
TSTulin R. Saylı
Tulin R. Saylı
To determine vitamin D supplementation frequency among children aged 1 to 24 months, factors that influence adherence, and reasons for discontinuation of initiated vitamin D.This cross-sectional st...

15 September 2019 in Zeynep Kamil Tıp Bülteni
Verified
Journal Article
Closed access
PDF file
SKSelen Hürmüzlü Közler
Selen Hürmüzlü Közler
SESerhat Emeksi̇z
Serhat Emeksi̇z
YAYasemin Men Atmaca
Yasemin Men Atmaca
GAGanime Ayar
Ganime Ayar
AGAlev Güven
Alev Güven
Konjenital muskuler distrofiler (KMD) nadir görülen, infant döneminde kas güçsüzlüğü ve motor gelişimde gecikme ile kendini gösteren bir grup hastalıktır. Bunların en ağır formlarından biri Walker Warburg Sendromu (WWS)' dur. WWS otozomal resesif geçişli, beyin ve göz anomalilerinin eşlik ettiği bir hastalıktır. Beyinde tip 2 lizensefali, beyaz cevherde hipomyelinizasyon, hidrosefali, korpus kallosum agenezisi, gözde katarakt, optik sinir displazisi, retinal displazi, lens defektleri görülür. Destek tedavisi verilse de oldukça mortal seyreder, ortalama yaşam ömrü dört ay civarındadır. Burada, klinik ve görüntüleme yöntemleriyle WWS düşünülen, kas biyopsisinde alfa distroglikan eksikliği görülerek tanısı desteklenen bir olgu sunulmuştur.

10 September 2026 in Turkish Journal of Pediatric Disease
Verified
Journal Article
Open access
PDF file
SKSelen Hürmüzlü Közler
Selen Hürmüzlü Közler
FKFatih Kilci
Fatih Kilci
ESEmre Sarıkaya
Emre Sarıkaya
NMNurhan Özcan Murat
Nurhan Özcan Murat
Objective: Differentiating Graves disease (GD) from Hashitoxicosis in children is often challenging due to overlapping clinical and biochemical features at presentation. This study aimed to evaluate the diagnostic utility of commonly available clinical and biochemical parameters to support etiologic classification in pediatric autoimmune thyrotoxicosis. Materials and Methods: We retrospectively analyzed 58 children aged 0–18 years diagnosed with autoimmune thyrotoxicosis between 2019 and 2025. Clinical, laboratory, and imaging findings were compared between patients with GD and Hashitoxicosis. Receiver operating characteristic (ROC) analysis and logistic regression were performed to assess the diagnostic performance of key parameters. Results: The cohort was female-predominant, with similar sex distribution between groups (34/44, 77.3% in GD vs 11/14, 78.6% in Hashitoxicosis). Palpitations were the most common presenting symptom (17, 29.3 %). Incidental detection occurred in 17 (29.3%), of whom 9 (52.9%) had subtle symptoms identified on detailed clinical evaluation. Ophthalmopathy was observed exclusively in GD (13, 29.5%). fT3 levels and the fT3/fT4 ratio were significantly higher in GD than in Hashitoxicosis (p = 0.002 and p = 0.001, respectively). TRAb showed the highest diagnostic performance (AUC = 0.950), followed by fT3 (AUC = 0.856) and the fT3/fT4 ratio (AUC = 0.809). A TRAb cut-off of 2.6 IU/L yielded 75% sensitivity and 100% specificity, whereas fT3 ≥6 pg/mL yielded 93% sensitivity and 46% specificity. Anti-TPO and anti-Tg antibodies showed poor discriminatory value. TRAb remained independently associated with GD (OR = 3.61, p = 0.011). Nine children with Hashitoxicosis (64.3%) were managed without treatment and achieved spontaneous resolution. Conclusion: Differentiating GD from Hashitoxicosis requires an integrated assessment of clinical features, antibody status, and hormone dynamics. TRAb remains the most informative marker, while fT3 and the fT3/fT4 ratio may provide complementary value. Anti-thyroid antibodies have limited utility for etiologic differentiation. Accurate classification helps guide the management and avoid unnecessary treatment.

18 September 2026 in Turkish Journal of Pediatric Disease
Verified
Journal Article
Open access
PDF file
ABAhmet ziya Birbilen
Ahmet ziya Birbilen
SKSelin Taşar Karabulut
Selin Taşar Karabulut
SKSelen Hürmüzlü Közler
Selen Hürmüzlü Közler
FKFunda Kurt
Funda Kurt
HYHalil İbRahim Yakut
Halil İbRahim Yakut
EMEmine Dibek Mısırlıoğlu
Emine Dibek Mısırlıoğlu
Objective: Extreme leukocytosis is often considered a warning sign of serious bacterial infection (SBI) in febrile children. However, its diagnostic value remains controversial, particularly in the post-vaccination era. This study aimed to evaluate whether extreme leukocytosis is associated with an increased risk of SBI compared with moderate leukocytosis in pediatric emergency patients. Materials and Methods: This single-center, retrospective comparative study included children aged 1 month to 18 years who presented to a tertiary pediatric emergency department in Ankara, Türkiye, with a white blood cell (WBC) count ≥15.000/mm³. Patients were classified into moderate (15.000–24.999/mm³) and extreme (≥25.000/mm³) leukocytosis groups. SBI frequency, C-reactive protein (CRP) levels, and multivariable predictors of SBI were analyzed. Results: A total of 955 patients were included (423 extreme, 532 moderate leukocytosis). SBI was identified in 26.0% of extreme and 22.7% of moderate leukocytosis patients (p=0.243). In multivariable analysis, extreme leukocytosis was not independently associated with SBI (OR 1.18, 95% CI 0.86–1.61, p=0.308), whereas CRP (OR 1.05, 95% CI 1.02–1.07, p=0.001) and fever (OR 2.21, 95% CI 1.54–3.16, p<0.001) were significant predictors. CRP showed moderate discriminatory ability (AUC 0.649), with improved performance in the extreme leukocytosis subgroup (AUC 0.705). Conclusion: Extreme leukocytosis was not associated with increased SBI risk compared with moderate leukocytosis. CRP provided independent predictive value and may serve as a more useful biomarker for SBI risk stratification in pediatric emergency patients with leukocytosis.

21 August 2026 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
SKSelen Hürmüzlü Közler
Selen Hürmüzlü Közler
FKFatih Kilci
Fatih Kilci
ESEmre Sarıkaya
Emre Sarıkaya
NMNurhan Özcan Murat
Nurhan Özcan Murat

19 April 2021 in Preprints.org
Verified
Preprint
Open access
PDF file
SKSelen Hürmüzlü Közler
Selen Hürmüzlü Közler
TSTulin Revide Sayli
Tulin Revide Sayli
Background: To determine vitamin D supplementation frequency among infants, factors that influence adherence, and reasons for discontinuation of initiated vitamin D. Methods: This cross-sectional study was conducted using a questionnaire administered to the mothers via a face-to-face interview on 560 infants aged from 1 to 24 months admitted to outpatient clinics from June to December 2017. Results: A total of 351 infants were administered vitamin D, and the rate of supplementation in the first year of life was 83%, while it was only 28% between 13 and 24 months. The rate of vitamin D supplementation was higher among infants who were exclusively formula-fed (p<.05). When the data were analyzed using logistic regression analysis, only visit family physicians seems to be a statistically significant independent variable in increasing supplementation (p<.05). Compared with family refusal, the rate of discontinuation of vitamin D by the healthcare providers was higher after the first year of life (p<.05). The rates of vitamin D discontinuation by healthcare providers, especially by nurses who considered the duration of supplementation adequate, were statistically significantly higher when compared with the fontanel closure and other reasons (p<0.05). Conclusions: The rate of vitamin D supplementation was higher among families who visited family physicians, which suggests the importance of well-baby visits. Since vitamin D supplementation was less common among exclusively breastfed infants, mothers should be educated. Healthcare professionals need further education about the importance of vitamin D supplementation and indications for discontinuation.